Form 4: P3 Health Partners Director Acquires Stock Options
SEC Form 4 Filing
Mark Thierer, a director of P3 Health Partners Inc., acquired 965,279 stock options on June 6, 2024, exercisable at $0.5461 per share.
Summary
- On June 6, 2024, Mark Thierer, a director of P3 Health Partners Inc., acquired 965,279 stock options.
- The options have an exercise price of $0.5461 per share.
- The options vest and become exercisable on the earlier of June 6, 2025, or the date of the next annual meeting of the Issuer's stockholders, contingent upon continued service.
- Thierer also has a power of attorney designating Aric Coffman, Leslie Fisher, and Atul Kavthekar to act on his behalf for SEC filings related to P3 Health Partners Inc.
Sentiment
Score: 6
Explanation: The document itself is neutral, simply reporting a transaction. The sentiment is slightly positive as it reflects a director's increased stake in the company, suggesting confidence.
Positives
- The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The document does not contain specific forward-looking statements regarding the company's future performance, but the vesting of the options is tied to continued service, suggesting an expectation of ongoing involvement.
Industry Context
This filing is a routine disclosure related to insider transactions, common in the healthcare industry and other publicly traded sectors. It provides transparency regarding the holdings and transactions of company insiders.
Comparison to Industry Standards
- Stock option grants are a common form of executive compensation in the healthcare industry, used to align management's interests with those of shareholders.
- The vesting schedule and exercise price are typical for such grants, often tied to continued employment and market conditions.
- Comparable companies like Oak Street Health or Alignment Healthcare also utilize stock options as part of their compensation packages.
Stakeholder Impact
- The acquisition of stock options by a director may have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| July 23, 2021 | Date of execution of the Power of Attorney. |
| June 6, 2024 | Date of transaction: Mark Thierer acquired stock options. |
| June 6, 2025 | Earliest vesting date for the stock options. |
| June 6, 2034 | Expiration date of the stock options. |
| June 10, 2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.